Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in USA in 2026

The United States leads the world in pharmaceutical spending as a share of GDP: 2.65 % GDP % in 2026, ranking 1-nd out of 197. This high figure stems not only from the high cost of innovative drugs but also from the absence of government price controls — pharmaceutical companies set prices freely, and patients and insurers bear the burden. In countries with strict price regulation, this indicator rarely exceeds 1.5 % of GDP.

Data for 2026 · unit: % GDP
Position

USA world ranking

#1 / 197

Country position on the scale from last to first place for this indicator.

US
#1
#197#1
Trend

Change over time

Change in indicator over the available period.

1.80
1990
2.20
2000
2.50
2010
2.60
2020
2.65
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in USA — how much?
Based on 2026 data — 2.65 % GDP. This is rank #1 out of 197 countries.
What is USA's rank by Pharmaceutical expenditure?
USA ranks #1 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in USA?
Over the available period the indicator changed from 1.80 to 2.65 % GDP.